24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis
Clinical trial NCT01989468 · COMPLETED
Trial details
- NCT number
- NCT01989468
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-10
- Primary completion
- 2015-05-27
- Enrollment
- 414
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.